Dubuque Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.39M | Buy |
36,127
+775
| +2% | +$114K | 0.72% | 37 |
|
|
2023
Q2 | $4.76M | Sell |
35,352
-809
| -2% | -$119K | 0.61% | 46 |
|
|
2023
Q1 | $5.76M | Sell |
36,161
-2,873
| -7% | -$439K | 0.74% | 38 |
|
|
2022
Q4 | $6.31M | Sell |
39,034
-7,306
| -16% | -$1.12M | 0.83% | 33 |
|
|
2022
Q3 | $6.22M | Sell |
46,340
-4,168
| -8% | -$598K | 0.87% | 35 |
|
|
2022
Q2 | $7.74M | Sell |
50,508
-1,831
| -3% | -$280K | 1% | 30 |
|
|
2022
Q1 | $8.48M | Sell |
52,339
-4,297
| -8% | -$624K | 0.95% | 35 |
|
|
2021
Q4 | $7.67M | Sell |
56,636
-1,780
| -3% | -$210K | 0.81% | 39 |
|
|
2021
Q3 | $6.3M | Sell |
58,416
-1,451
| -2% | -$166K | 0.71% | 47 |
|
|
2021
Q2 | $6.74M | Sell |
59,867
-4,336
| -7% | -$488K | 0.75% | 46 |
|
|
2021
Q1 | $6.95M | Sell |
64,203
-4,124
| -6% | -$441K | 0.79% | 40 |
|
|
2020
Q4 | $7.32M | Buy |
68,327
+105
| +0.2% | +$10.1K | 0.9% | 32 |
|
|
2020
Q3 | $5.97M | Sell |
68,222
-3,953
| -5% | -$372K | 0.88% | 34 |
|
|
2020
Q2 | $7.09M | Sell |
72,175
-4,617
| -6% | -$407K | 1.1% | 27 |
|
|
2020
Q1 | $5.85M | Sell |
76,792
-6,736
| -8% | -$574K | 1.1% | 25 |
|
|
2019
Q4 | $7.4M | Sell |
83,528
-8,503
| -9% | -$706K | 1.13% | 21 |
|
|
2019
Q3 | $6.97M | Buy |
92,031
+2,259
| +3% | +$155K | 1.13% | 25 |
|
|
2019
Q2 | $6.53M | Sell |
89,772
-530
| -0.6% | -$41.7K | 1.05% | 34 |
|
|
2019
Q1 | $7.28M | Buy |
90,302
+4,255
| +5% | +$348K | 1.17% | 29 |
|
|
2018
Q4 | $7.93M | Buy |
86,047
+1,104
| +1% | +$97.1K | 1.43% | 18 |
|
|
2018
Q3 | $8.03M | Buy |
84,943
+2,141
| +3% | +$203K | 1.24% | 21 |
|
|
2018
Q2 | $7.67M | Buy |
82,802
+17,325
| +26% | +$1.69M | 1.26% | 20 |
|
|
2018
Q1 | $6.2M | Buy |
65,477
+22,404
| +52% | +$2.46M | 1% | 25 |
|
|
2017
Q4 | $4.17M | Buy |
43,073
+37,700
| +702% | +$3.55M | 0.63% | 47 |
|
|
2017
Q3 | $478K | Sell |
5,373
-95
| -2% | -$7.23K | 0.08% | 121 |
|
|
2017
Q2 | $396K | Sell |
5,468
-355
| -6% | -$23.9K | 0.09% | 135 |
|
|
2017
Q1 | $379K | Sell |
5,823
-591
| -9% | -$37.2K | 0.08% | 122 |
|
|
2016
Q4 | $402K | Buy |
6,414
+2,758
| +75% | +$168K | 0.07% | 113 |
|
|
2016
Q3 | $231K | Sell |
3,656
-1,254
| -26% | -$81.2K | 0.04% | 145 |
|
|
2016
Q2 | $304K | Buy |
4,910
+702
| +17% | +$42.8K | 0.06% | 147 |
|
|
2016
Q1 | $240K | Buy |
4,208
+1,763
| +72% | +$98.3K | 0.05% | 168 |
|
|
2015
Q4 | $145K | Buy |
2,445
+132
| +6% | +$7.6K | 0.03% | 225 |
|
|
2015
Q3 | $126K | Buy |
2,313
+333
| +17% | +$21.7K | 0.03% | 227 |
|
|
2015
Q2 | $133K | Buy |
1,980
+630
| +47% | +$41.1K | 0.02% | 238 |
|
|
2015
Q1 | $79K | Buy |
1,350
+900
| +200% | +$54.4K | 0.01% | 237 |
|
|
2014
Q4 | $29K | Hold |
450
| – | – | ﹤0.01% | 359 |
|
|
2014
Q3 | $26K | Hold |
450
| – | – | ﹤0.01% | 386 |
|
|
2014
Q2 | $25K | Sell |
450
-100
| -18% | -$5.25K | ﹤0.01% | 428 |
|
|
2014
Q1 | $28K | Buy |
550
+100
| +22% | +$5.05K | 0.01% | 267 |
|
|
2013
Q4 | $24K | Hold |
450
| – | – | ﹤0.01% | 279 |
|
|
2013
Q3 | $20K | Hold |
450
| – | – | ﹤0.01% | 273 |
|
|
2013
Q2 | $19K | Buy |
+450
| New | +$19.7K | ﹤0.01% | 245 |
|
Other funds holding ABBV
Dubuque Bank & Trust's ABBV Position: Q3 2023 in Review
Dubuque Bank & Trust increased its AbbVie (ABBV) stake by 2.2% in Q3 2023, buying an estimated $114K and bringing the position to 36,127 shares worth $5.39M. The position accounts for 0.72% of the portfolio, ranked #37.
Dubuque Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.48M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Dubuque Bank & Trust held 36,127 shares of AbbVie worth $5.39M as of Q3 2023.
- Dubuque Bank & Trust bought 775 AbbVie shares in Q3 2023, an estimated $114K.
- AbbVie made up 0.72% of Dubuque Bank & Trust's portfolio in Q3 2023, its #37 holding.
- Dubuque Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 42 quarters since.
- Dubuque Bank & Trust's AbbVie position peaked at $8.48M in Q1 2022.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Dubuque Bank & Trust's 13F filing for Q3 2023, filed 27 Oct 2023.